These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 150085)

  • 1. The detection and measurement of pretransplant sensitization.
    Carpenter CB; Morris PJ
    Transplant Proc; 1978 Jun; 10(2):509-13. PubMed ID: 150085
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse presensitization: detection by utilization of B lymphoblastoid cell panels.
    Suthanthiran M; Fotino M; Gibofsky A; Cheigh JS; Stenzel KH; Rubin AL; Novogrodsky A
    Transplant Proc; 1979 Jun; 11(2):1263-4. PubMed ID: 382502
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-donor cell-mediated responses. Pretransplant lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) in kidney transplantation.
    Myburgh JA; Smit JA
    Transplant Proc; 1978 Jun; 10(2):425-7. PubMed ID: 354131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-immunologic problems in kidney transplantation].
    Lanzer G
    Wien Med Wochenschr; 1981; 131(6):139-43. PubMed ID: 6455015
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocyte migration inhibitory factor (LIF) as an indicator of presensitization and allograft survival.
    Cochrum KC; Haynes DM; Salvatierra O; Feduska NJ; Vincenti F; Van Speybroeck J
    Transplant Proc; 1978 Jun; 10(2):455-8. PubMed ID: 150081
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 7. MLC inhibitory alloantibodies and outcome of kidney allografts.
    Suciu-Foca N; Hardy M; Kiamar M; Weiner J; Susinno E; Molinaro AP; Jacob J; Reemtsma K
    Transplant Proc; 1978 Jun; 10(2):493-5. PubMed ID: 150083
    [No Abstract]   [Full Text] [Related]  

  • 8. MLR inhibitory activity of pretransplant anti-donor B cell antibodies, and kidney graft survival.
    Lenhard V; Diehm H; Rettwitz W; Dreikorn K
    Proc Eur Dial Transplant Assoc; 1981; 18():433-8. PubMed ID: 6460245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte migration inhibitory factor (LIF) as an indicator of mixed lymphocyte culture (MLC) reactivity.
    Cochrum KC; Salvatierra O; Cullen BL; Perkins HA; Hanes DM; Fudenberg HH
    Transplant Proc; 1977 Mar; 9(1):97-101. PubMed ID: 141146
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of T cell sensitization in renal transplant patients with mixed lymphocyte culture-cell-mediated lympholysis.
    Suranyi MG; Hall BM; Duggin GG; Horvath JS; Johnson JR; Sheil AG; Tiller DJ
    Transplant Proc; 1987 Apr; 19(2):2873-5. PubMed ID: 2951917
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) with bone-marrow graft rejection in HLA-identical siblings.
    Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
    Transplant Proc; 1978 Jun; 10(2):433-4. PubMed ID: 354133
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro measurement of sensitization to rat marrow allografts.
    Klein DL; Bateman JL; Sepelak SB; Tutschka PJ; Elfenbein GJ; Santos GW
    Transplant Proc; 1978 Jun; 10(2):435-40. PubMed ID: 354134
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of tolerance to allogeneic kidney grafts in irradiated reconstituted adult rats.
    Dittmer J; Moran T; Bennett M
    Transplantation; 1979 Sep; 28(3):263-5. PubMed ID: 158864
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic monitoring in cardiac transplantation.
    Devineni R; McKenzie N; Keown P; Stiller C; Hellstrom A; Banerjee D
    Transplant Proc; 1984 Dec; 16(6):1576-9. PubMed ID: 6239427
    [No Abstract]   [Full Text] [Related]  

  • 15. D lucus antigen defined lymphoblastoid cell panel allows detection of hitherto undetected adverse presensitization.
    Suthanthiran M; Fotino M; Cheigh JS; Novogrodsky A; Rubin AL; Stenzel KH
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():199-202. PubMed ID: 386312
    [No Abstract]   [Full Text] [Related]  

  • 16. Variation in T and B cell deficiency in different mouse allogeneic radiation chimeras.
    Urso P; Gengozian N
    J Immunol; 1974 Dec; 113(6):1770-9. PubMed ID: 4279262
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.
    Hirschberg H; Moen T; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):776-8. PubMed ID: 377711
    [No Abstract]   [Full Text] [Related]  

  • 18. A variant of severe combined immunodeficiency with normal in vitro response to allogeneic cells and an increase in circulating B lymphocytes persisting several months after successful bone marrow graft.
    Seligmann M; Griscelli C; Preud'homme JL; Sasportes M; Herzog C; Brouet JC
    Clin Exp Immunol; 1974 Jun; 17(2):245-52. PubMed ID: 4282850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired B-cell tolerance in complete as compared with mixed chimeras after allogeneic bone marrow transplantation.
    Waer M; Salam A; Vandeputte M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1281-2. PubMed ID: 8442112
    [No Abstract]   [Full Text] [Related]  

  • 20. Presensitization of potential kidney recipients detected by cell kinetic studies in the pooled mixed lymphocyte reaction.
    Lenhard V; Tittor W
    Transplant Proc; 1978 Jun; 10(2):447-9. PubMed ID: 150079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.